FDA clears Dexcom Stelo as the first OTC CGM for children, raising new questions around app access, caregiver oversight, school device rules, and reimbursement.

Insulet Corporation (PODD) and DexCom (DXCM) were among notable gainers in MedTech on Tuesday after Deutsche Bank initiated the diabetes device makers with Buy ratings despite their sharp sell-off in ...

The FDA has given the green light to Dexcom’s popular over-the-counter glucose monitor Stelo for children two years or older who don’t use insulin. The regulatory agency previously cleared the glucose ...

Add Yahoo as a preferred source to see more of our stories on Google. Dexcom received FDA clearance for its first over-the-counter continuous glucose monitor, called Stelo. The device is intended for ...

Following expanded FDA approval for pediatric patients, the over-the-counter Stelo continuous glucose monitor is adding AI ...

Check the settings on Apple Watch, Galaxy Watch, Pixel Watch, Huawei Watch, and Garmin that can affect glucose alerts, ...

Following up on its landmark FDA clearance for pediatric use earlier this month, Dexcom is backing up its newly expanded hardware reach with an AI-driven app overhaul. Unveiled at the Aspen Ideas: ...

AI may help smartwatches make glucose data more useful through better predictions, pattern detection, and personalized health ...

DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today announced at Aspen Ideas: Health a series of milestones that advance its vision of making glucose biosensing more accessible ...

June 11 (Reuters) - Drug wholesaler Pharmsource LLC said it was unaware the Dexcom (DXCM.O), opens new tab glucose sensors it bought from licensed distributors had been ‌slated for destruction, after ...

June 12 (Reuters) - The U.S. Food and Drug Administration said on Friday it has expanded the use of Dexcom's (DXCM.O), opens new tab Stelo Glucose Biosensor ‌System to children with diabetes, making ...